Meridiem Capital Partners LP Bruker Corp Transaction History
Meridiem Capital Partners LP
- $1.42 Trillion
- Q2 2025
A detailed history of Meridiem Capital Partners LP transactions in Bruker Corp stock. As of the latest transaction made, Meridiem Capital Partners LP holds 354,281 shares of BRKR stock, worth $12.3 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
354,281Holding current value
$12.3 Million% of portfolio
1.03%Shares
1 transactions
Others Institutions Holding BRKR
# of Institutions
407Shares Held
117MCall Options Held
237KPut Options Held
747K-
T. Rowe Price Investment Management, Inc. Baltimore, MD11.4MShares$398 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$363 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.83MShares$342 Million0.01% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.5MShares$331 Million16.14% of portfolio
-
Orbis Allan Gray LTD Hamilton, D04.68MShares$163 Million1.26% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $5.16B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...